par Roer, Louise;Yin, Nicolas
;Denis, Olivier
;Vendrik, Karuna Ew;Zwittink, Romy RD;Notermans, Daan W;Perrin, Monique;Khonyongwa, Kirstin;Tristan, Anne;Youenou, Benjamin;Layer-Nicolaou, Franziska;Werner, Guido;Enger, Hege;Eikrem, Emily Charlotte Henry;Darenberg, Jessica;Mäkitalo, Barbro;Paulsson, Magnus;Björkman, Jonas;Fang, Hong;Hallbäck, Erika Tång;Sundqvist, Martin;Lindholm, Laura;Moganeradj, Kartyk;García-Cobos, Silvia;Cañada-García, Javier JE;Holzknecht, Barbara Juliane;Eriksen, Helle Brander;Hoppe, Morten;Bartels, Mette Damkjær;Samaniego Castruita, Jose Alfredo;Urth, Tinna Ravnholt;Larsen, Anders Rhod;Petersen, Andreas
Référence Euro surveillance, 30, 28
Publication Publié, 2025-07-01


Référence Euro surveillance, 30, 28
Publication Publié, 2025-07-01
Article révisé par les pairs
Résumé : | We describe the genetic characteristics of a fusidic acid- and meticillin-resistant Staphylococcus aureus (MRSA) clone widespread in Europe, based on whole genome sequences from 317 isolates. The clone is causing impetigo and other skin and soft tissue infections, primarily in young children. Comparison with publicly available S. aureus ST121 sequences showed that the clone is clearly distinct from previously described ST121 clones. European and other international readers should be aware of the emergence of this community-acquired MRSA clone. |